4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide has been researched along with Hyperlipemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, Y; Kurogi, Y; Nagao, K; Nakamura, S; Tsuda, Y; Tsutsumi, K; Yoshitsugu, H | 1 |
| Tsutsumi, K | 1 |
| Mutoh, M; Niho, N; Sugimura, T; Takahashi, M; Tsutsumi, K; Wakabayashi, K | 1 |
| Mutoh, M; Niho, N; Wakabayashi, K | 1 |
| Goto, K; Kondo, M; Morioka, Y; Naito, S; Nakamura, S; Tsutsumi, K | 1 |
| Inoue, Y; Tsutsumi, K; Yoshida, C | 1 |
| Inoue, Y; Murase, T; Tsutsumi, K | 1 |
2 review(s) available for 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and Hyperlipemia
| Article | Year |
|---|---|
Lipoprotein lipase and atherosclerosis.
Topics: Animals; Benzamides; Cholesterol, HDL; Coronary Artery Disease; Enzyme Activators; Hyperlipidemias; Hypolipidemic Agents; Lipoprotein Lipase; Organophosphorus Compounds; Triglycerides | 2003 |
Concomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity in Apc-deficient mice.
Topics: Age Factors; Animals; Benzamides; Bezafibrate; Cyclooxygenase 2; Genes, APC; Humans; Hyperlipidemias; Intestinal Polyps; Lipoprotein Lipase; Membrane Proteins; Mice; Organophosphorus Compounds; Pioglitazone; PPAR alpha; PPAR gamma; Thiazolidinediones; Triglycerides | 2006 |
5 other study(ies) available for 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and Hyperlipemia
| Article | Year |
|---|---|
Synthesis and hypolipidemic activities of novel 2-[4-[diethoxyphosphoryl)methyl]phenyl]quinazolines and 4(3H)-quinazolinones.
Topics: Animals; Arteriosclerosis; Benzamides; Biological Availability; Cholesterol; Chromatography, High Pressure Liquid; Hyperlipidemias; Hypolipidemic Agents; Magnetic Resonance Spectroscopy; Molecular Structure; Organophosphorus Compounds; Polyethylene Glycols; Quinazolines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Triglycerides | 1996 |
Concurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice.
Topics: Animals; Anticarcinogenic Agents; Benzamides; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cyclooxygenase 2; Female; Hyperlipidemias; Hypolipidemic Agents; Intestinal Polyps; Lipoprotein Lipase; Mice; Mice, Inbred C57BL; Organophosphorus Compounds; Prostaglandin-Endoperoxide Synthases; RNA, Messenger | 2005 |
Synthesis and biological activity of the metabolites of diethyl 4-[(4-bromo-2-cyanophenyl)carbamoyl]benzylphosphonate (NO-1886).
Topics: Animals; Benzamides; Biotransformation; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Hyperlipidemias; Lipoprotein Lipase; Magnetic Resonance Spectroscopy; Male; Organophosphorus Compounds; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Triglycerides | 1996 |
Suppression of hyperlipidemia-associated cataracts in diabetic rats with the lipoprotein lipase activator NO-1886.
Topics: Animals; Benzamides; Blood Glucose; Cataract; Cholesterol, Dietary; Diabetes Mellitus, Experimental; Enzyme Activation; Hyperlipidemias; Lipids; Lipoprotein Lipase; Male; Organophosphorus Compounds; Rats; Rats, Wistar; Risk Factors | 1996 |
Effects of NO-1886, a lipoprotein lipase promoting agent, on homozygous and heterozygous Watanabe heritable hyperlipidaemic rabbits.
Topics: Animals; Benzamides; Heterozygote; Homozygote; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoprotein Lipase; Male; Organophosphorus Compounds; Rabbits | 2000 |